NCT00000354View on ClinicalTrials.gov

Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3

PHASE1CompletedINTERVENTIONAL
0
Timeline

Start Date

July 31, 1996

Primary Completion Date

September 30, 1997

Study Completion Date

December 31, 1997

Conditions
Opioid-Related DisordersSubstance-Related Disorders
Interventions
DRUG

Lofexidine

Trial Locations (1)

19104 6178

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

University of Pennsylvania

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00000354 - Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3 | Biotech Hunter | Biotech Hunter